Advertisement

Search Results for "Cmax Of Estradiol 25 Mcg Tablets"

14:27 EDT 19th May 2013 | BioPortfolio

Original Source: Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

The purpose of the study is to determine the bioequivalence of Norgestimate (NGM) and Ethinyl Estradiol (EE) in 2 formulations of 250 mcg NGM/25 mcg EE, 1 without folic acid and 1 containing 400 mcg folic acid. The pharmacokinetics of blood folate from the formulation of 250 mcg NGM/25 mcg EE containing 400 mcg folic acid and from 400 mcg folic acid administered alone is characterized.

Matching Channels

Telehealth

Telehealth uses communication devices such as computers, mobiles and tablets to deliver healthcare. For example, many patients monitor their condition using a telehealth computer which can take read...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Luteinizing Hormone LH

Luteinizing hormone (LH), a gonadotropin, stimulates the gonads - in males, the testes, and in females, the ovaries. It is essential for reproduction, and secreted from cells in the anterior pituita...

Types of laxatives

Laxatives are medicines that relieve constipation (difficulty with bowel movements). They are a popular type of over-the-counter remedy. They can also be prescribed for conditions that could get wor...

Matching News

FDA Approves Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy

JERUSALEM--(BUSINESS WIRE)--Mar. 29, 2013-- Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Quartette (levonorgestrel/ethinyl estradio...

FDA approves Teva's Quartette tablets for prevention of pregnancy

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets for the preventio...

Lupin obtains final FDA marketing approval for Daysee tablets

Lupin Pharmaceuticals has obtained final marketing approval from FDA for its Daysee tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.15mg/0.03mg and Ethinyl Estradiol Tablets, USP, 0.01mg...

US FDA accepts Teva's Quartette NDA

The US Food and Drug Administration has accepted for filing the New Drug Application for Quartette (levonorgestrelethinyl estradiol tablets and ethinyl estradiol tablets), filed by Teva Women's Health...

FDA accepts Teva's NDA for Quartette oral contraceptive

Teva Women's Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the U.S. Food and Drug Administration has accepted for filing its New Drug Application f...

Teva’s Quartette data support US filing

Teva Women’s Health has reported Phase III clinical data for its novel, dose-ascending extended-regimen oral contraceptive Quartette. The new product, which contains levonorgestrel/ethinyl estr...

FDA Okays New Extended-Regimen Oral Contraceptive

Levonorgestrel/ethinyl estradiol and ethinyl estradiol tablets were designed to minimize breakthrough bleeding between scheduled periods. FDA Approvals

Teva Women's Health, Inc. Announces for the First Time Results of Pivotal Phase III Study of Quartette (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) at the 68th Annual Meeting of ASRM

- Data Demonstrate that Efficacy of a Novel Ascending-Dose, Extended-Regimen Oral Contraceptive is Similar to Other Oral Contraceptives - FRAZER, Pa.--(BUSINESS WIRE)--Oct 24, 2012 - Teva Women's Heal...

Matching PubMed Articles

Pharmacokinetic comparison of two 4 mg tablet formulations of tizanidine.

Objectives: To assess the bioequivalence of two Tizanidine 4 mg tablet formulations (Tizanidine® of the Pharma International company, as test product, and Sirdalud® of Novartis as a reference produc...

Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake.

Scope: The distribution and accumulation of olive oil phenolic compounds in the body are topics lacked of information. The aim of this study was to evaluate the bioavailability, metabolism and distrib...

Comparison of pharmacokinetics in beagle dogs of nimesulide bilayer tablets with dispersible tablets.

The purpose of this study was to compare the in vitro release and the in vivo pharmacokinetics of bilayer tablets with the conventional dispersible tablets of nimesulide. The tablets were administered...

Dissolution profile of 24 levofloxacin (100 mg) tablets.

Although there are 23 generic levofloxacin (100 mg) tablets (LVFX tablets) and 1 brand name LVFX tablet (supply now discontinued) in Japan, there have been no reports that have evaluated and compared...

Physico-chemical comparison of famotidine tablets prepared via dry granulation and direct compression techniques.

Famotidine is generally employed for the treatment of gastric ulcer. The present study was conducted to fabricate famotidine tablets using various diluents. The binder was incorporated to the formulat...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement